Quipt Home Medical (QIPT) Competitors

Oncology Institute (NASDAQ:TOI) and Quipt Home Medical (NASDAQ:QIPT) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, valuation, profitability, media sentiment, dividends, earnings, institutional ownership and risk.

Which has more risk and volatility, TOI or QIPT?

Oncology Institute has a beta of 0.08, indicating that its stock price is 92% less volatile than the S&P 500. Comparatively, Quipt Home Medical has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500.

Is TOI or QIPT more profitable?

Quipt Home Medical has a net margin of -4.30% compared to Oncology Institute's net margin of -14.26%. Quipt Home Medical's return on equity of -9.78% beat Oncology Institute's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oncology Institute	-14.26%	-1,527.21%	-34.25%
Quipt Home Medical	-4.30%	-9.78%	-4.23%

Does the media prefer TOI or QIPT?

In the previous week, Quipt Home Medical had 8 more articles in the media than Oncology Institute. MarketBeat recorded 11 mentions for Quipt Home Medical and 3 mentions for Oncology Institute. Quipt Home Medical's average media sentiment score of 0.98 beat Oncology Institute's score of 0.88 indicating that Quipt Home Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oncology Institute	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Quipt Home Medical	3 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do insiders and institutionals hold more shares of TOI or QIPT?

36.9% of Oncology Institute shares are owned by institutional investors. Comparatively, 42.9% of Quipt Home Medical shares are owned by institutional investors. 8.5% of Oncology Institute shares are owned by insiders. Comparatively, 13.4% of Quipt Home Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Do analysts rate TOI or QIPT?

Oncology Institute presently has a consensus price target of $7.00, suggesting a potential upside of 84.70%. Quipt Home Medical has a consensus price target of $3.15, suggesting a potential upside of 46.51%. Given Oncology Institute's stronger consensus rating and higher probable upside, equities research analysts plainly believe Oncology Institute is more favorable than Quipt Home Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oncology Institute	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.33
Quipt Home Medical	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Which has preferable valuation & earnings, TOI or QIPT?

Quipt Home Medical has lower revenue, but higher earnings than Oncology Institute. Quipt Home Medical is trading at a lower price-to-earnings ratio than Oncology Institute, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oncology Institute	$393.41M	0.86	-$64.66M	-$0.68	-5.57
Quipt Home Medical	$245.91M	0.38	-$6.76M	-$0.24	-8.96

Summary

Quipt Home Medical beats Oncology Institute on 10 of the 17 factors compared between the two stocks.